| March 2008 |
Tunnell Consulting Expands Biotechnology Expertise
Dr. Siddharth Advant Appointed Head of West Coast Office
|
| |
KING OF PRUSSIA, PA, MARCH 4, 2008 — Continuing its leadership as an advisor to the life sciences industries, Tunnell Consulting announced that it has appointed Siddharth Advant, Ph.D., as head of its West Coast office, located in San Diego, California. Dr. Advant brings more than a decade of process development, technology transfer, manufacturing, regulatory and business experience to Tunnell's West Coast operations, which was established in 2006 to service the unique needs of the area's fast growing biotech industry.
"Sid Advant's tremendous experience in biotechnology and biologics is a perfect fit for the type of services we offer to leading companies,” said Conrad Heilman, Ph.D., Tunnell's Senior Vice President and Life Sciences Strategy Leader. "Having participated in the development of more than two dozen therapeutic proteins, Dr. Advant's knowledge of the intricacies, challenges and opportunities in commercializing multiple protein expression systems will help deliver extraordinary results for our clients.”
Recognized as one of Inc. Magazine's fastest growing privately held companies in 2007, the King of Prussia-based company has a significant history of assisting leading life science companies in the United States and Europe. Tunnell provides companies with technical and developmental services to optimize manufacturing, compliance, risk mitigation, cost reduction and regulatory strategies. The San Diego staff works with Tunnell's King of Prussia, Washington, D.C., and San Juan offices to service clients' operations across multiple product lines and locations.
"I'm delighted to join an accomplished firm such as Tunnell, which has built a team of highly experienced senior executives whose collective expertise and success in biotech processes offers an unparalleled resource for companies of all sizes across the U.S., as well as internationally,” said Dr. Advant. ”I look forward to working in the West Coast biotech hub and contributing to the culture of innovation and discovery by building alliances with researchers and exploring opportunities with business leaders.”
In 2007, the West Coast Office hosted a series of events designed to create an advanced learning community to benefit the state's life sciences industry. These seminars featured thought leaders and senior executives from several of the region's premier biotech firms, who provided perspective about the latest developments, challenges, and solutions in drug development and quality control, as well as the adoption of advanced production techniques.
About Siddharth
Advant Prior to joining Tunnell, Siddharth Advant, Ph.D. was a Director for Diosynth Biotechnology, heading three primary areas: Project Management & Business Alliances, Technology Transfer & Clinical Operations, and Pharmaceutical Sciences & Stability. In these positions, Dr. Advant was responsible for technical and financial execution of customer projects, development and implementation of technology transfer programs, as well as building and managing an analytical, formulation and cGMP testing laboratory. He worked as a scientist in the pharmaceutical development division at Protein Design Labs, Inc. and as a Program Manager for BioReliance, Inc. where he supervised a cGMP/GLP compliant formulation development business.
Dr. Advant earned a B.S. degree in pharmacy from the University of Poona, India and a Ph.D. in Pharmaceutics from the University of Connecticut School of Pharmacy. He is a Founding Member of the CMC Strategy Forum Advisory Committee, which consists of FDA and Industry members, and served as Chair for the 2008 WCBP Meeting, 2004 AAPS National Biotechnology Conference in Boston and the 2002 AAPS Biotechnology Section. The author of various peer-reviewed articles, Dr. Advant has also made a number of scientific presentations at major industry conferences.
About Tunnell Consulting
King of Prussia, PA-based Tunnell Consulting integrates strategic, technical, process and organizational skills to boost its clients" business performance. Founded in 1962, Tunnell focuses on the life sciences industry and government agencies, designing and implementing sustainable solutions that improve operating performance. The firm draws on the expertise of its accomplished multi-disciplinary professionals with experience in industry, government and research. Working with many of the world's leading companies and the public sector, Tunnell implements value-added, cost-effective solutions that fit the unique needs of each client they serve. More information may be found at www.tunnellconsulting.com. |
| |
| October 2007 |
|
Tunnell Consulting Included in Inc. Magazine's List of 5,000 Fastest Growing Private Companies |
| |
King of Prussia, PA – October 30, 2007 – Tunnell Consulting today announced that it has been included in the 2007 edition of Inc. magazine's 5,000 fastest growing privately held American companies. The King of Prussia advisor to the life science industry grew 67.3 percent between 2003 and 2006. The Inc. 5,000 is an extension of Inc.'s original list of 500 and was developed to include many larger companies that are too big to grow at the pace required to be included in the Inc. 500 list.
"We are proud to be included in a list that recognizes the entrepreneurial spirit of so many great companies," said Joseph S. Tempio, Ph.D., Tunnell's President and CEO. "Our growth is the result of providing our partners in the pharmaceutical and biotechnology industries exceptional value across a wide range of services. Their continued confidence in us and desire to keep engaging Tunnell validates our belief that by focusing exclusively on life sciences, we can offer clients a very tailored and unique set of services that help them excel."
Tunnell Consulting, which has been featured in the Philadelphia Business Journal and Smart Business Philadelphia has 62 employees and recently opened offices in San Diego, CA and San Juan, Puerto Rico to better serve those communities' life science companies. Based in King of Prussia, PA, Tunnell Consulting integrates strategic, technical, process and organizational skills to boost its clients' business performance. Founded in 1962, Tunnell focuses on the life sciences industry and government agencies, designing and implementing sustainable solutions that improve operating performance. The firm draws on the expertise of its accomplished multi-disciplinary professionals with experience in industry, government and research. Working with many of the world's leading companies and the public sector, Tunnell implements value-added, cost-effective solutions that fit the unique needs of each client they serve. |
| |
| June 2007 |
| Tunnell Consulting Announces Opening of Puerto Rico Office |
| |
KING OF PRUSSIA, PA, – JUNE 7, 2007 – Tunnell Consulting, a leading advisor to the life sciences industry, today announced the opening of a San Juan, Puerto Rico office to better serve the Island's significant pharmaceutical and biotechnology community. Founded in 1962, the Pennsylvania-headquartered company has a long history of assisting life science companies in the United States, Europe and Puerto Rico with technical and development services including manufacturing optimization, compliance support, risk mitigation, and clinical and regulatory strategy.
The San Juan office will be headed by Richard A. Winegar, a Tunnell Principal with more than 20 years of experience in consulting and manufacturing operations management. Prior to joining Tunnell, Winegar served as Director of Manufacturing Operations-Latin America for a division of American Home Products and Operations Manager-Puerto Rico for American Cyanamid.
"Since Rick joined Tunnell, he has assisted pharmaceutical and biotech clients in implementing critical organizational change projects, developing global product sourcing strategies, and assessing manufacturing capacity and performance," said Joseph S. Tempio, Ph.D., Tunnell's President and CEO. "His operations expertise and understanding of the Puerto Rico market make him the ideal person to head this effort."
Tunnell's new Puerto Rico office follows on the heels of the 2006 opening of an office in San Diego, California, which serves the West Coast's life science industries, particularly the biologic and biotechnology industry, and the opening of an office in Washington DC, to serve the US Government's Life Science-related departments and initiatives.
Working with Tunnell's team in Puerto Rico will also be Jaime Velez, a Principal and Supply Chain Practice Leader for Tunnell. "Jaime's extensive life sciences consulting experience in implementing Lean Six Sigma methodologies and pull systems in supply chain operations, as well as senior level manufacturing operations experience, adds significant expertise to the services we offer through our Puerto Rico office," added Conrad Heilman, Ph.D., Vice President and Leader of Tunnell's Life Sciences Strategic Operating Unit.
Puerto Rico has long been a global center for pharmaceutical and medical device manufacturing. With recent investments by some of the world's largest biotech corporations, Puerto Rico is solidifying its position as a premier site for biotechnology manufacturing. Currently, 16 of the top 20 drugs sold in the U.S. are manufactured in Puerto Rico.
"We have extended our expertise and capabilities in the U.S. as our clients' needs have grown," said Rick Winegar. "With the opening of our new office in San Juan, we can continue to provide superior services to our increasingly global customers while responding more rapidly to the unique needs of our clients in Puerto Rico."
Tunnell's staff in Puerto Rico will work with its King of Prussia, PA, New York City, Washington, D.C., and San Diego offices to service the unique needs of Puerto Rico's Life Sciences industry.
About Richard Winegar
A graduate of Columbia University with a Master's Degree in Business Administration, Richard Winegar is an expert in operations management. He brings more than 20 years of manufacturing management and consulting experience to Tunnell Consulting's new office. He has helped clients through challenging business transitions and dramatic organizational change. He has managed domestic and international chemical processing and packaging operations; led global client teams in strategy implementation and site consolidation, and directed significant compliance remediation events. While Director of Manufacturing Operations in Latin America for American Cyanamid, Winegar led the development of regional manufacturing strategies, achieved significant plant operations cost reductions and managed outsourced manufacturing services.
Winegar has lived in Puerto Rico for a number of years.
About Tunnell Consulting
King of Prussia, PA-based Tunnell Consulting integrates strategic, technical, process and organizational skills to boost its clients' business performance. Founded in 1962, Tunnell focuses on the life sciences industry and government agencies, designing and implementing sustainable solutions that improve operating performance. The firm draws on the expertise of its accomplished multi-disciplinary professionals with experience in industry, government and research. Working with many of the world's leading companies and the public sector, Tunnell implements value-added, cost-effective solutions that fit the unique needs of each client they serve. More information may be found at www.tunnellconsulting.com.
|
| |
| May 2007 |
Jaime Velez to Lead Tunnell Consulting's
Supply Chain Management Practice
|
| |
King of Prussia, Pa – May 14, 2007 – Tunnell Consulting, Inc. today announced that Jaime Velez has been named head of the firm's Supply Chain Management Practice to which he brings extensive experience in designing, teaching and implementing continuous improvement methodologies such as Lean Manufacturing and Six Sigma in supply chain and manufacturing operations.
"Facing increasing competitive and cost pressures, leading companies are striving to extract more value from their supply chains," said Joseph S. Tempio, Ph.D., Tunnell's President and CEO. "Jaime Velez brings to our team the comprehensive skills in manufacturing and supply chain that will help our clients lead the way to continuously improve performance."
Prior to joining Tunnell Mr. Velez served in the Operations Management practice of McKinsey & Company where he focused on serving pharmaceutical and medical device clients. Previously, as an independent consultant, he guided the European division of a U.S.-based company through their transformation to Lean Manufacturing. Prior to that, he served as Vice President of Advanced Manufacturing for General Cable Corporation, a producer of wire and cable products for the energy, industrial, and communications industries. Previously, he was Vice President of Operations for Laird Technologies and held senior level supply chain and operations management positions at Thomas & Betts Corporation, Square D Company and Eaton-Cutler Hammer.
"For more than 40 years, Tunnell has helped companies of all kinds achieve breakthrough improvement in supply chain management," said Mr. Velez. "I'm delighted to be joining a team that has earned a well-deserved reputation for delivering extraordinary business results for clients."
Mr. Velez holds a B.S. in Industrial Engineering from Stanford University.
About Tunnell Consulting
King of Prussia, PA-based Tunnell Consulting integrates strategic, technical, process and organizational skills to boost its clients' business performance. Founded in 1962, Tunnell focuses on the life sciences industry and government agencies, designing and implementing sustainable solutions that improve operating performance. The firm draws on the expertise of its accomplished multi-disciplinary professionals with experience in industry, government and research. Working with many of the world's leading companies and the public sector, Tunnell implements value-added, cost-effective solutions that fit the unique needs of each client they serve. More information may be found at www.tunnellconsulting.com.
|
| |
| March 2007 |
Tunnell Consulting Names Dr. Philippe Cini Vice President
PAT and Process Expert to Continue to Serve Life Sciences Clients
|
| |
King of Prussia, Pa – March 6th, 2007 – Tunnell Consulting, Inc. today announced that Philippe Cini, Ph.D., has been named a vice president in the firm's Life Sciences practice.
"Philippe, as leader of our manufacturing process excellence services, provides our life sciences and pharmaceutical clients with the expertise to make their processes efficient, cost effective, robust and of high quality," said Dr. Tempio, President and CEO of Tunnell "He has also been in the forefront of our Process Analytical Technology (PAT) /Quality by Design Program, dedicated to helping life sciences organizations realize maximum benefits from the FDA's PAT and QbD initiatives."
In addition to being a manufacturing process expert, Dr. Cini has provided consulting services to the pharmaceutical industry in various areas of operations management in the United States, Puerto Rico, Europe, and Latin America.
Dr. Cini previously worked at Bristol-Myers Squibb, where he helped lead the implementation of the $7.8 billion DuPont Pharmaceuticals acquisition. To his work at Tunnell he also brings his experience from Gemini Consulting and Cap Gemini Ernst and Young Group, where he was responsible for major projects for pharmaceutical companies around the world.
Dr. Cini received his Ph.D. in Chemical Engineering from the University of Massachusetts and his M.Sc. in Chemical Engineering from Université Nancy, France.
About Tunnell Consulting
King of Prussia, PA-based Tunnell Consulting integrates strategic, technical, process and organizational skills to boost its clients' business performance. Founded in 1962, Tunnell focuses on the life sciences industry and government agencies, designing and implementing sustainable solutions that improve operating performance. The firm draws on the expertise of its accomplished multi-disciplinary professionals with experience in industry, government and research. Working with many of the world's leading companies and the public sector, Tunnell implements value-added, cost-effective solutions that fit the unique needs of each client they serve. More information may be found at www.tunnellconsulting.com.
|
| |
| October 2006 |
Tunnell Consulting Establishes West Coast Presence
|
| |
King of Prussia, Pa - October 10, 2006 - Recognizing the important role of California's biotechnology industry in advancing life science discovery and innovation, Tunnell Consulting has opened an office in San Diego, California to better serve the area's biologic, biotech, device and diagnostic industries. Founded in 1962, the King of Prussia-based company has a long history of assisting life sciences companies in the United States and Europe with technical and development services including manufacturing optimization, compliance support, risk mitigation and clinical and regulatory strategy. With more than 500 biomedical companies in greater San Diego and Southern California, Tunnell's consultants will work with its King of Prussia, PA and New York City offices to service the unique needs of California's fast growing biotech industry.
"Our new operations in San Diego enable us to more effectively assist our clients in implementing innovative therapeutic solutions and delivering extraordinary results," said Joseph S. Tempio, Ph.D., Tunnell's President and CEO.
The opening of Tunnell's West Coast office is the most recent example of the firm's continued emphasis on maintaining its position as a major life sciences consultancy. In August, the American Statistical Association named Tunnell's Ron Snee its 2006 Deming Lecturer Award Winner for his work in advancing the study and implementation of Six Sigma process improvements. Dr. Snee's award follows the May announcement that The U.S. Department of Health and Human Services (HHS) awarded Tunnell Consulting a multi-million dollar, multi-year contract to provide staffing support to assist HHS in preparing for a potential global avian influenza pandemic.
About Tunnell Consulting
King of Prussia, PA-based Tunnell Consulting integrates strategic, technical, process and
organizational skills to boost its clients' business performance. Founded in 1962, Tunnell
focuses on the life sciences industry and government agencies, designing and
implementing sustainable solutions that improve operating performance. The firm draws on
the expertise of its accomplished multi-disciplinary professionals with experience in
industry, government and research. Working with many of the world's leading companies
and the public sector, Tunnell implements value-added, cost-effective solutions that fit the
unique needs of each client they serve. More information may be found at
www.tunnellconsulting.com
|
| |
| August 2006 |
| Ronald Snee, Ph.D. Named 2006 Deming Lecturer Award Winner |
Tunnell Consulting, Inc. is pleased to announce that our Six Sigma expert Dr. Ron Snee has won another prestigious honor related to his dedicated work in fostering process improvement approaches in American industry. The American Statistical Association has named Dr. Snee its 2006 Deming Lecturer Award Winner; in making the announcement, Dr. Snee was cited for his ongoing accomplishments in the use of statistical methodology and statistical thinking, "thus extending the impact of many of Dr. Deming's ideas." Dr. Snee is a well-known national authority on Six Sigma applications, has won more than 20 top honors for his work in the field, has written 3 books, and has published over 165 articles on varying aspects of Six Sigma effectiveness and success.
|
 |
| |
The Deming Lecturer Award is conferred each year on a person who honors the groundbreaking philosophy and methods of quality pioneer Dr. W. Edwards Deming, a world-renowned champion of quality improvement in all aspects of organizational performance. The award is designed to honor individual recipients by acknowledging their advancement of Dr. Deming's landmark work, and by applauding their own accomplishments in the field. In announcing the award, Dr. Snee was recognized for consulting, books, and research that have promoted major improvements in quality management, and for "advances in the use of mixture experiments and in the successful implementation of Six Sigma programs and methodology."
In addition to this award, Dr. Snee has also previously won leading honors from the American Society for Quality: he is the recipient of ASQ's respected Shewhart and Grant medals. To learn more about Dr. Snee's books and articles, please click here.
|
| |
| July
2006 |
Joseph J. Villafranca, Ph.D. to Direct Tunnell Consulting's Life Sciences Practice
|
King of Prussia, Pa - July 31, 2006 - Tunnell Consulting, Inc. has announced that
Joseph J. Villafranca, Ph.D., has joined the firm to direct its Life Sciences practice, and will focus on biopharmaceutical and pharmaceutical clients
and assist in the firm's pandemic flu preparedness work with the U.S. Department of
Health and Human Services.
"As an experienced executive in pharmaceuticals and biopharmaceuticals, Joe Villafranca
brings unparalleled expertise to the challenges our clients face," said President and CEO,
Joseph S. Tempio, Ph.D. "In addition, his extensive experience in drug development
makes him an invaluable member of our flu preparedness team."
Over the course of his career, Dr. Villafranca has worked as a consultant to the industry as
well as an executive in such areas as strategic planning, alliance management,
pharmaceutical development and manufacturing, and biopharmaceuticals strategy.
"I'm delighted to join a firm with a long-established reputation for excellence throughout
the life sciences industry," said Dr. Villafranca. "The unique ability to contribute not only to
clients' business strategy but also to manufacturing and regulatory strategy and
implementation puts Tunnell in the forefront of life sciences consulting."
Prior to joining Tunnell, Dr. Villafranca led Biopharmaceutical Consultants, offering
services to pharmaceutical and biotechnology industries in strategic planning, drug
discovery, drug development, manufacturing, portfolio planning, project management and
executive coaching. Previously, he served as Executive Vice President, Pharmaceutical
Development and Operations, at Neose Technologies, where he had broad
responsibilities for strategic and corporate planning, alliance management,
pharmaceutical development and manufacturing.
Prior to that, he held a number of positions at Bristol-Myers Squibb, including responsibility
for biologics strategy, biopharmaceutical operations, and drug discovery. Previously, he
taught at Pennsylvania State University, where he was the Evan Pugh Professor of
Chemistry and published more than 180 primary research and review papers.
About Tunnell Consulting
With offices in San Diego and New York and a joint venture in Washington, DC, King of
Prussia, PA-based Tunnell Consulting integrates strategic, technical, process and
organizational skills to boost its clients' business performance. Founded in 1962, Tunnell
focuses on the life sciences industry and government agencies, designing and
implementing sustainable solutions that improve operating performance. The firm draws
on the expertise of its accomplished multi-disciplinary professionals with experience in
industry, government and research. Working with many of the world's leading companies
and the public sector, Tunnell creates lasting business relationships by providing the right
people with the right solutions and results. |
| |
| June
2006 |
Joseph Tempio, Ph.D. Named Chairman of Tunnell Consulting
Frank
Ecock, Conrad Heilman, Marian Preston, Dwight Porter
and Susan Devane Elected to the Board |
King of Prussia, Pa -
June 23, 2006 - Tunnell
Consulting, Inc. today announced that Joseph S. Tempio, Ph.D., President
and Chief Executive Officer, was named Chairman of the company
at its Board meeting on April 27, 2006. Dr. Tempio, who will continue
as President and CEO, succeeds Robert P. Hill as Chairman.
"At
a time when Tunnell is enjoying robust growth and continuing to
fulfill its long-established reputation for delivering extraordinary
value to clients, I'm honored to have the opportunity to help lead
our team of exceptional professionals," said Dr. Tempio. "For more
than 40 years, Tunnell has been a leader in providing innovative
solutions to all of the industries we serve, and we expect to continue
that leadership. Our process improvement capabilities including
tools such as Lean Six Sigma and multivariate data analysis integrate
powerful and proven improvement methodologies and provide our clients
with the ability to get at the root causes of problems and solve
them once and for all. Our experience in delivering technical expertise
to the pharmaceutical and life sciences industry has made us a
leader in helping clients address the FDA's Process Analytical
Technology initiative and compliance and operations challenges.
From supply chain management to government services, Tunnell and
its people will continue to be known for unsurpassed excellence
in consulting." Tunnell was recently awarded a $32 million dollar
five year contract to work with US Department of Health and Human
Services supporting avian flu preparedness, and also is working
with the National Institutes of Health on workforce planning and
operational and organizational effectiveness.
Dr. Tempio was named
CEO in April 2005 and previously served as President of Tunnell.
During his tenure as President, Dr. Tempio oversaw the restructuring
of Tunnell!|s business into three successful strategic operating
units designed to deliver unexcelled services to our clients. Previously,
Dr. Tempio headed the firm's largest practice, Life Sciences Technical
Services beginning in 1999, leading the practice through its greatest
growth period despite a difficult economy.
Before joining Tunnell, Dr. Tempio held significant positions
in the pharmaceutical industry, including President of IBAH Pharmaceutics
Services (now Omnicare Clinical Services), Director of Scientific
Affairs for Lederle Consumer Healthcare (now a division of Wyeth),
Director of Scientific Affairs at SmithKline Beecham Consumer Health
(now GlaxoSmithKline), and key R&D, and international positions
at SmithKline and teaching positions at Rutgers College of Pharmacy
in New Jersey. Dr. Tempio earned a B.S.
degree in pharmacy from Duquesne University, and M.S. and Ph.D.
degrees in pharmaceutical sciences from Rutgers the State University
of New Jersey.
At the April 27 shareholders meeting, the Board also
announced the election of its directors for 2006. They include
Dr. Tempio, Chairman; Marian Preston, Corporate Secretary; Dr.
Conrad J. Heilman, Jr., Vice President of Life Sciences; Susan
C. Devane, Vice President of Marketing and Sales; Dr. Dwight Porter,
President of Applied Decision Resources, Inc.; and Frank Ecock
(VP Operations, retired-Merck).
About Tunnell Consulting
With offices in San Diego and New York and a joint venture in Washington,
DC, King of Prussia, PA-based Tunnell Consulting integrates strategic,
technical, process and organizational skills to boost its clients'
business performance. Founded in 1962, Tunnell focuses on the
life sciences industry and government agencies, designing and
implementing sustainable solutions that improve operating performance.
The firm draws on the expertise of its accomplished multi-disciplinary
professionals with experience in industry, government and research.
Working with many of the world's leading companies and the public
sector, Tunnell creates lasting business relationships by providing
the right people with the right solutions and results. |
| |
| May 2006 |
Tunnell Consulting Awarded Contract to Fight Avian Flu
Joins U.S. Government Efforts to Prepare for Possible Pandemic Influenza |
King of Prussia, Pa - May 15, 2006 - The U.S. Department of Health and
Human Services (HHS) has awarded Tunnell Consulting a multi-million dollar
labor-hours type contract to provide staffing support to assist HHS in preparing
for a potential global influenza pandemic. Tunnell will work directly with the Office
of Research and Development Coordination (ORDC) within the Office of the
Secretary. This award provides for a base year at up to $6,450,000 if the
Government buys all 31,960 labor hours in the contract. The contract also
includes four oneyear options at $6,450,000 per year, for a potential total of
$32,250,000. This award continues Tunnell's history of providing consulting
services to more than two dozen government agencies.
ORDC is increasing significantly the scope and breadth of its Pandemic Influenza
Program as the U.S. government prepares for the spread of avian flu. According
to the United Nations and the World Health Organization, the highly pathogenic
H5N1 strain of avian flu virus has killed an estimated 200 million birds and
infected more than 200 people in Asia, Africa and the Middle East. At least 113
people have died, more than half of those infected. The human cases involved
persons who had contact with birds. All cases have occurred outside the United
States.
Many noted scientists say it is only a matter of time before avian flu infection is
found in birds in North America. The worldwide concern is that rapid spread
among birds could lead to a virus mutation that would sustain human-to-human
transmission. Such sustained human transmission has not occurred anywhere
globally that has been identified. However, the threat is real since humans have
no natural immunity to the H5N1 virus.
Under the contract, Tunnell Consulting, which is headquartered in King of Prussia
PA, will provide expertise and personnel to support ORDC in achieving five
central objectives:
- Establishing pandemic vaccines and influenza antiviral drug stockpiles
- Developing and manufacturing cell-based vaccines
- Establishing secure egg supply for influenza vaccine manufacturing
- Expanding and enhancing the vaccine surge supply
- Developing pandemic vaccine candidates for clinical evaluation
Tunnell has a long history of consulting in the life sciences field and strong
experience in the vaccine business and antiviral drug production. Tunnell's highly
educated, experienced and skilled life sciences professionals will provide
scientific and technical expertise to ORDC. Tunnell will supply project managers
and a variety of specialists in clinical affairs, process development,
manufacturing, scale-up and regulatory affairs to the Pandemic Influenza
Program. Tunnell personnel will be supported from the Washington D.C. office of
Tunnell's Government Services Group which administers its MOBIS contracts.
"We are pleased to be chosen by ORDC to support Secretary Leavitt's efforts in
preparing the nation for a possible avian flu pandemic," said Conrad Heilman, a
Ph.D. virologist and Vice President of Life Sciences at Tunnell. "The Secretary
has shown strong leadership in raising national awareness and preparedness for
this threat and we are eager to lend our best efforts and personnel to support this
initiative," he said.
The current U.S. capacity for manufacturing influenza vaccines is not sufficient to
supply the entire U.S. population in the event of a pandemic. Additionally, there
are insufficient stockpiles of antiviral drugs that are effective against avian flu.
Tunnell personnel will support ORDC's work with contractors, industry and other
necessary parties to expand the U.S. supply of pandemic vaccines and antiviral
drugs and develop an effective supply chain.
Tunnell President and CEO Joseph Tempio, Ph.D., says Tunnell is in the
distinctive position of providing qualified staff to the Office of Research and
Development Coordination. "For decades, we have been helping the life sciences
industry solve its most difficult problems," Tempio said. "We know the industry
and the public sector. We understand their processes and we know how to get
things done." Since the early 1990's, Tunnell has worked on projects for
government agencies including the National Institutes of Health and the
Department of Homeland Security.
About Tunnell Consulting
King of Prussia, PA-based Tunnell Consulting integrates strategic, technical,
process and organizational skills to boost its clients' business performance.
Founded in 1962, Tunnell focuses on the life sciences industry and government
agencies, designing and implementing sustainable solutions that improve
operating performance. The firm draws on the expertise of its accomplished
multi-disciplinary professionals with experience in industry, government and
research. Working with many of the world's leading companies and the public
sector, Tunnell creates lasting business relationships by providing the right
people with the right solutions and results.
|
| |
| |
|
